These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35707712)

  • 1. Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing.
    Gatla H; Uth N; Levinson Y; Navaei A; Sargent A; Ramaswamy S; Friedrich Ben-Nun I
    Front Med Technol; 2022; 4():850565. PubMed ID: 35707712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End-to-End Platform for Human Pluripotent Stem Cell Manufacturing.
    Pandey PR; Tomney A; Woon MT; Uth N; Shafighi F; Ngabo I; Vallabhaneni H; Levinson Y; Abraham E; Friedrich Ben-Nun I
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the scalable manufacture of primary human T-cells in an automated stirred-tank bioreactor.
    Costariol E; Rotondi M; Amini A; Hewitt CJ; Nienow AW; Heathman TRJ; Micheletti M; Rafiq QA
    Biotechnol Bioeng; 2019 Oct; 116(10):2488-2502. PubMed ID: 31184370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commercial Scale Manufacturing of Allogeneic Cell Therapy.
    Pigeau GM; Csaszar E; Dulgar-Tulloch A
    Front Med (Lausanne); 2018; 5():233. PubMed ID: 30186836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstrating the Manufacture of Human CAR-T Cells in an Automated Stirred-Tank Bioreactor.
    Costariol E; Rotondi MC; Amini A; Hewitt CJ; Nienow AW; Heathman TRJ; Rafiq QA
    Biotechnol J; 2020 Sep; 15(9):e2000177. PubMed ID: 32592336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-scale expansion of adipose-derived stromal cells starting from stromal vascular fraction in a single-use bioreactor: proof of concept for autologous applications.
    Gadelorge M; Bourdens M; Espagnolle N; Bardiaux C; Murrell J; Savary L; Ribaud S; Chaput B; Sensebé L
    J Tissue Eng Regen Med; 2018 Jan; 12(1):129-141. PubMed ID: 27943660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.
    Laco F; Lam AT; Woo TL; Tong G; Ho V; Soong PL; Grishina E; Lin KH; Reuveny S; Oh SK
    Stem Cell Res Ther; 2020 Mar; 11(1):118. PubMed ID: 32183888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of a new ambr250® bioreactor vessel for improved cell and gene therapy applications.
    Rotondi M; Grace N; Betts J; Bargh N; Costariol E; Zoro B; Hewitt CJ; Nienow AW; Rafiq QA
    Biotechnol Lett; 2021 May; 43(5):1103-1116. PubMed ID: 33528693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells.
    Sin WX; Jagannathan NS; Teo DBL; Kairi F; Fong SY; Tan JHL; Sandikin D; Cheung KW; Luah YH; Wu X; Raymond JJ; Lim FLWI; Lee YH; Seng MS; Soh SY; Chen Q; Ram RJ; Tucker-Kellogg L; Birnbaum ME
    Nat Biomed Eng; 2024 Jun; ():. PubMed ID: 38834752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from static culture to stirred tank bioreactor for the allogeneic production of therapeutic discogenic cell spheres.
    Rodriguez-Granrose D; Zurawski J; Heaton W; Tandeski T; Dulatov G; Highsmith AA; Conen M; Clark G; Jones A; Loftus H; LeBaron C; Scull E; Farhang N; Erickson I; Bingham J; Decaria P; Jones N; Foley KT; Silverman L
    Stem Cell Res Ther; 2021 Aug; 12(1):455. PubMed ID: 34384480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle to needle robot-assisted manufacture of cell therapy products.
    Ochs J; Hanga MP; Shaw G; Duffy N; Kulik M; Tissin N; Reibert D; Biermann F; Moutsatsou P; Ratnayake S; Nienow A; Koenig N; Schmitt R; Rafiq Q; Hewitt CJ; Barry F; Murphy JM
    Bioeng Transl Med; 2022 Sep; 7(3):e10387. PubMed ID: 36176619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products.
    Lee B; Borys BS; Kallos MS; Rodrigues CAV; Silva TP; Cabral JMS
    Bioengineering (Basel); 2020 Mar; 7(2):. PubMed ID: 32231012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor.
    Fitzgerald JC; Duffy N; Cattaruzzi G; Vitrani F; Paulitti A; Mazzarol F; Mauro P; Sfiligoj A; Curcio F; Jones DM; McInerney V; Krawczyk J; Kelly J; Finnerty A; McDonagh K; McCabe U; Duggan M; Connolly L; Shaw G; Murphy M; Barry F
    Front Bioeng Biotechnol; 2022; 10():834267. PubMed ID: 35356775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes.
    Sousa MF; Silva MM; Giroux D; Hashimura Y; Wesselschmidt R; Lee B; Roldão A; Carrondo MJ; Alves PM; Serra M
    Biotechnol Prog; 2015; 31(6):1600-12. PubMed ID: 26289142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biomanufacturing platform for large-scale and high-quality human T cells production.
    Ou J; Si Y; Tang Y; Salzer GE; Lu Y; Kim S; Qin H; Zhou L; Liu X
    J Biol Eng; 2019; 13():34. PubMed ID: 31044002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel automated bioreactor for scalable process optimisation of haematopoietic stem cell culture.
    Ratcliffe E; Glen KE; Workman VL; Stacey AJ; Thomas RJ
    J Biotechnol; 2012 Oct; 161(3):387-90. PubMed ID: 22771559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an automated manufacturing process for large-scale production of autologous T cell therapies.
    Francis N; Braun M; Neagle S; Peiffer S; Bohn A; Rosenthal A; Olbrich T; Lollies S; Ilsmann K; Hauck C; Gerstmayer B; Weber S; Kirkpatrick A
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101114. PubMed ID: 37790245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies.
    Ganeeva I; Zmievskaya E; Valiullina A; Kudriaeva A; Miftakhova R; Rybalov A; Bulatov E
    Bioengineering (Basel); 2022 Dec; 9(12):. PubMed ID: 36551014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piloting a scale-up platform for high-quality human T-cells production.
    Selvarajan V; Teo DBL; Chang CC; Ng YL; Cheong N; Sivalingam J; Khoo SHG; Wong A; Loo BLW
    Front Cell Dev Biol; 2024; 12():1427171. PubMed ID: 39071806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR-T Cell Expansion in a Xuri Cell Expansion System W25.
    Smith TA
    Methods Mol Biol; 2020; 2086():151-163. PubMed ID: 31707674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.